亚洲 · 区域市场 · Mint
Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside
PL Capital believes the company is well positioned to benefit from increasing pharmaceutical outsourcing, a deep commercial pipeline and capacity expansion
在 Mint 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.livemint.com)
